PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Medical Genetics, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.\', \'School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Anesthesiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Biology, Islamic Azad University, Jahrom Branch, Jahrom, Iran.\', \'Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies\' Shiraz University of Medical Sciences, Shiraz, Iran.\', \'Division of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, MO, USA.\', \'Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Neurogenic Inflammation Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.\', \'Polish Mother\'s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1080/14787210.2020.1822737
?:doi
?:hasPublicationType
?:journal
  • Expert review of anti-infective therapy
is ?:pmid of
?:pmid
?:pmid
  • 32921216
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.264
?:rankingScore_hIndex
  • 62
is ?:relation_isRelatedTo_publication of
?:title
  • COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all